Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2011; 17(1): 79-88
Published online Jan 7, 2011. doi: 10.3748/wjg.v17.i1.79
Figure 3
Figure 3 Downregulation of miR-143 and miR-145 in esophageal squamous cell carcinoma. Using the 2-ΔΔCt method, those with a greater than 2-fold change were considered significant. The expression of miR-143 was downregulated in 48.9% (46/94) and miR-145 was downregulated in 60.6% (57/94) clinical samples of esophageal carcinoma.